# Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

> **NCT00910117** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 40 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** nimotuzumab
- **DRUG:** PF regimen (cisplatin and 5-FU)

## Key facts

- **NCT ID:** NCT00910117
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00910117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00910117, "Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00910117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*